Skip to main content
Top
Published in: BMC Women's Health 1/2019

Open Access 01-12-2019 | Research article

Life situation of women impaired by Thalidomide embryopathy in North Rhine-Westphalia - a comparative analysis of a recent cross-sectional study with earlier data

Authors: Christina Samel, Christian Albus, Irmgard Nippert, Alexander Niecke, Markus Lüngen, Holger Pfaff, Klaus M. Peters

Published in: BMC Women's Health | Issue 1/2019

Login to get access

Abstract

Background

Between 1957 and 1961 the substance Thalidomide was sold in West Germany and taken by many women as a sedative during pregnancy. This lead to miscarriages and infants been born with several severe malformations. The aim of this study was to describe the current situation of women impaired by Thalidomide induced embryopahty in North Rhine-Westphalia (Nordrhein-Westfalen), Germany, in comparison with the results found in a study done in 2002 by Nippert et al.

Methods

Questionnaires as well as examinations were performed. Data were compared using descriptive and inductive statistical methods.

Results

Both studies show that women impaired by Thalidomide embryopathy face a poorer health status than women their age in the general population and live in fear of further deteriorating health. The majority can only work reduced hours or are already retired due to poor health. Most of those who need assistance are being assisted by their social environment, while professional care is still utilized in only few cases.

Conclusions

An obvious need for a shift in the provision of assistance and/or care provided was found as the social environment supporting the impaired women is also aging and therefore in high danger of breaking apart.

Trial registration

The study has been registered at German Clinical Trials Register, DRKS00010593, on 07.06.2016 retrospectively.
Literature
3.
go back to reference Zuckerplätzchen forte. Der Spiegel. 1961:59–60. Zuckerplätzchen forte. Der Spiegel. 1961:59–60.
4.
go back to reference Gefahr im Verzuge. Der Spiegel. 1962:72–90. Gefahr im Verzuge. Der Spiegel. 1962:72–90.
6.
go back to reference Der KB. Contergan-Fall: eine unvermeidbare Arzneimittelkatastrophe? Zur Geschichte des Arzneistoffes Thalidomid. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1999. Der KB. Contergan-Fall: eine unvermeidbare Arzneimittelkatastrophe? Zur Geschichte des Arzneistoffes Thalidomid. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1999.
9.
go back to reference Niethard FU, Marquard E, Eltze J, editors. Contergan: 30 Jahre danach. Stuttgart: Ferdinand Enke Verlag; 1994. Niethard FU, Marquard E, Eltze J, editors. Contergan: 30 Jahre danach. Stuttgart: Ferdinand Enke Verlag; 1994.
10.
go back to reference Strömland K, Nordin V, Miller M, et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol. 1994;36(4):351–6.CrossRef Strömland K, Nordin V, Miller M, et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol. 1994;36(4):351–6.CrossRef
13.
go back to reference Withdrawal of Thalidomide from the Market. Can Med Assoc J 1962;86(14):664. Withdrawal of Thalidomide from the Market. Can Med Assoc J 1962;86(14):664.
19.
go back to reference Singhal S, Mehta J. Thalidomide in cancer. Biomed Pharmacother. 2002;56(1):4–12.CrossRef Singhal S, Mehta J. Thalidomide in cancer. Biomed Pharmacother. 2002;56(1):4–12.CrossRef
23.
go back to reference Stephens T, Brynner R. Dark remedy: The impact of thalidomide and its revival as a vital medicine. Cambridge: Perseus; 2001. Stephens T, Brynner R. Dark remedy: The impact of thalidomide and its revival as a vital medicine. Cambridge: Perseus; 2001.
24.
go back to reference Marwick C. Thalidomide back--under strict control. JAMA. 1997;278(14):1135–7.CrossRef Marwick C. Thalidomide back--under strict control. JAMA. 1997;278(14):1135–7.CrossRef
25.
go back to reference Zeldis JB, Williams BA, Thomas SD, et al. S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide. Clin Ther. 1999;21(2):319–30.CrossRef Zeldis JB, Williams BA, Thomas SD, et al. S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide. Clin Ther. 1999;21(2):319–30.CrossRef
28.
go back to reference Kruse A, Ding-Greiner C, Becker G, et al. CONTERGAN Wiederholt durchzuführende Befragung zu Problemen, speziellen Bedarfen und Versorgungsdefiziten von contergangeschädigten Menschen. Heidelberg: Endbericht an die Conterganstiftung für behinderte Menschen; 2012. Kruse A, Ding-Greiner C, Becker G, et al. CONTERGAN Wiederholt durchzuführende Befragung zu Problemen, speziellen Bedarfen und Versorgungsdefiziten von contergangeschädigten Menschen. Heidelberg: Endbericht an die Conterganstiftung für behinderte Menschen; 2012.
29.
go back to reference Peters KM, Albus C, Lüngen M, et al. Gesundheitsschäden, psychosoziale Beeinträchtigungen und Versorgungsbedarf von contergangeschädigten Menschen aus Nordrhein-Westfalen in der Langzeitperspektive: Forschungsbericht. Studie im Auftrag des Landeszentrums Gesundheit Nordrhein-Westfalen 2015. Peters KM, Albus C, Lüngen M, et al. Gesundheitsschäden, psychosoziale Beeinträchtigungen und Versorgungsbedarf von contergangeschädigten Menschen aus Nordrhein-Westfalen in der Langzeitperspektive: Forschungsbericht. Studie im Auftrag des Landeszentrums Gesundheit Nordrhein-Westfalen 2015.
30.
go back to reference Nippert I, Edler B, Schmidt-Herterich C. 40 years later: the health related quality of life of women affected by thalidomide. Community Genet. 2002;5(4):209–16.PubMed Nippert I, Edler B, Schmidt-Herterich C. 40 years later: the health related quality of life of women affected by thalidomide. Community Genet. 2002;5(4):209–16.PubMed
31.
go back to reference Wittchen HU, Zaudig M, Fydrich T. Strukturiertes klinisches Interview für DSM-IV: Achse I und II. Göttingen: Hogrefe; 1997. Wittchen HU, Zaudig M, Fydrich T. Strukturiertes klinisches Interview für DSM-IV: Achse I und II. Göttingen: Hogrefe; 1997.
32.
go back to reference Spitzer RL, Williams JB, Gibbon M, et al. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):624–9.CrossRef Spitzer RL, Williams JB, Gibbon M, et al. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):624–9.CrossRef
33.
go back to reference Spitzer RL, Williams J, Gibbon M. First, M.B. Structured clinical interview for DSM-III-R. Washington D.C.: American Psychiatric Press; 1990. Spitzer RL, Williams J, Gibbon M. First, M.B. Structured clinical interview for DSM-III-R. Washington D.C.: American Psychiatric Press; 1990.
34.
go back to reference First MB, Gibbon M, Spitzer RL, et al. Structured clinical interview for DSM-IV Axis II personality disorders, (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.; 1997. First MB, Gibbon M, Spitzer RL, et al. Structured clinical interview for DSM-IV Axis II personality disorders, (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.; 1997.
36.
go back to reference The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group. Psychol Med. 1998;28(3):551–8.CrossRef The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group. Psychol Med. 1998;28(3):551–8.CrossRef
37.
go back to reference Angermeyer MC, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF: Handbuch für die deutschsprachige Version der WHO Instrumente zur ERfassung von Lebensqualität. Göttingen: Hogrefe Verlag; 2000. Angermeyer MC, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF: Handbuch für die deutschsprachige Version der WHO Instrumente zur ERfassung von Lebensqualität. Göttingen: Hogrefe Verlag; 2000.
38.
go back to reference Morfeld M, Kirchberger I, Bullinger M. SF-36 Fragebogen zum Gesundheitszustand: Deutsche Version des Short Form-36 Health Survery. 2nd ed. Göttingen: Hogrefe; 2011. Morfeld M, Kirchberger I, Bullinger M. SF-36 Fragebogen zum Gesundheitszustand: Deutsche Version des Short Form-36 Health Survery. 2nd ed. Göttingen: Hogrefe; 2011.
39.
go back to reference Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRef Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRef
41.
go back to reference The EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef The EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
42.
go back to reference Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.CrossRef Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.CrossRef
52.
go back to reference Jacobi F, Höfler M, Siegert J, et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the mental health module of the German health interview and examination survey for adults (DEGS1-MH). Int J Methods Psychiatr Res. 2014;23(3):304–19. https://doi.org/10.1002/mpr.1439.CrossRefPubMed Jacobi F, Höfler M, Siegert J, et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the mental health module of the German health interview and examination survey for adults (DEGS1-MH). Int J Methods Psychiatr Res. 2014;23(3):304–19. https://​doi.​org/​10.​1002/​mpr.​1439.CrossRefPubMed
57.
go back to reference Meltzer JW, Hochstim JR. Reliability and validity of survey data on physical health. Public Health Rep. 1970;85(12):1075–86.CrossRef Meltzer JW, Hochstim JR. Reliability and validity of survey data on physical health. Public Health Rep. 1970;85(12):1075–86.CrossRef
58.
go back to reference Rasooly I, Papageorgiou AC, Badley EM. Comparison of clinical and self reported diagnosis for rheumatology outpatients. Ann Rheum Dis. 1995;54(10):850–2.CrossRef Rasooly I, Papageorgiou AC, Badley EM. Comparison of clinical and self reported diagnosis for rheumatology outpatients. Ann Rheum Dis. 1995;54(10):850–2.CrossRef
59.
go back to reference Warren MD. Interview surveys of handicapped people: the accuracy of statements about the underlying medical conditions. Rheumatol Rehabil. 1976;15(4):295–302.CrossRef Warren MD. Interview surveys of handicapped people: the accuracy of statements about the underlying medical conditions. Rheumatol Rehabil. 1976;15(4):295–302.CrossRef
60.
go back to reference Schrag A, Brown RJ, Trimble MR. Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms. J Neurol Neurosurg Psychiatry. 2004;75(4):608–11.CrossRef Schrag A, Brown RJ, Trimble MR. Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms. J Neurol Neurosurg Psychiatry. 2004;75(4):608–11.CrossRef
Metadata
Title
Life situation of women impaired by Thalidomide embryopathy in North Rhine-Westphalia - a comparative analysis of a recent cross-sectional study with earlier data
Authors
Christina Samel
Christian Albus
Irmgard Nippert
Alexander Niecke
Markus Lüngen
Holger Pfaff
Klaus M. Peters
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2019
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-019-0745-y

Other articles of this Issue 1/2019

BMC Women's Health 1/2019 Go to the issue